[HTML][HTML] PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up

MC Operti, A Bernhardt, S Grimm, A Engel… - International Journal of …, 2021 - Elsevier
Nanomedicines based on poly (lactic-co-glycolic acid)(PLGA) carriers offer tremendous
opportunities for biomedical research. Although several PLGA-based systems have already …

[HTML][HTML] Diabetes mellitus and diabetic foot ulcer: Etiology, biochemical and molecular based treatment strategies via gene and nanotherapy

AVA Mariadoss, AS Sivakumar, CH Lee… - Biomedicine & …, 2022 - Elsevier
Diabetes mellitus (DM) is a collection of metabolic and pathophysiological disorders
manifested with high glucose levels in the blood due to the inability of β-pancreatic cells to …

Therapeutic applications of AS1411 aptamer, an update review

R Yazdian-Robati, P Bayat, F Oroojalian… - International journal of …, 2020 - Elsevier
Nucleolin or C23, is one of the most abundant non-ribosomal phosphoproteins of nucleolus.
However, in several cancers, nucleolin is highly expressed both intracellularly and on the …

Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy

Z Fu, J **ang - International Journal of Molecular Sciences, 2020 - mdpi.com
Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer
therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using …

The design of poly (lactide-co-glycolide) nanocarriers for medical applications

D Essa, PPD Kondiah, YE Choonara… - … in bioengineering and …, 2020 - frontiersin.org
Polymeric biomaterials have found widespread applications in nanomedicine, and poly
(lactide-co-glycolide),(PLGA) in particular has been successfully implemented in numerous …

Aptamers in biomedicine: Selection strategies and recent advances

G Ștefan, O Hosu, K De Wael, MJ Lobo-Castañón… - Electrochimica …, 2021 - Elsevier
Aptamers have come in the spotlight as bio-mimetic molecular recognition elements in the
field of biomedicine due to various applications in diagnostics, drug delivery, therapeutics …

Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years

NA D'Angelo, MA Noronha, MCC Câmara… - Biomaterials …, 2022 - Elsevier
Doxorubicin (DOX) is a natural antibiotic with antineoplastic activity. It has been used for
over 40 years and remains one of the most used drugs in chemotherapy for a variety of …

Anti-nucleolin aptamer AS1411: an advancing therapeutic

A Van den Avont, N Sharma-Walia - Frontiers in Molecular …, 2023 - frontiersin.org
Targeted therapy is highly desirable, as it allows for selective cytotoxicity on diseased cells
without off-target side effects. Nucleolin is a remarkable target for cancer therapy given its …

Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery

TS Dongsar, TT Dongsar, N Molugulu… - Environmental …, 2023 - Elsevier
Breast carcinoma is a molecularly diverse illness, and it is among the most prominent and
often reported malignancies in female across the globe. Surgical intervention …

Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs

M Hashemi, A Shamshiri, M Saeedi, L Tayebi… - Archives of biochemistry …, 2020 - Elsevier
Most problems associated with chemotherapeutic agents involve non-specific cytotoxicity,
low intratumoral accumulation and drug resistance. Targeted drug delivery systems (TDDS) …